Related Experiment Video
Updated: Dec 21, 2025

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Published on: February 16, 2020
Ultrasound in managing extrapulmonary tuberculosis: a randomized controlled two-center study
Robert Ndege1,2, Omary Ngome3,4, Farida Bani3,5
1Ifakara Health Institute, Ifakara, United Republic of Tanzania, Off Mlabani Passage, P. O Box 53, Ifakara, Tanzania. rndege@ihi.or.tz.
This study evaluates ultrasound (eFASH) combined with other tests to improve diagnosis of extrapulmonary tuberculosis in Tanzania. The goal is to reduce incorrect tuberculosis treatment and improve patient management.
Area of Science:
- Infectious Diseases
- Medical Imaging
- Clinical Trials
Background:
- Extrapulmonary tuberculosis diagnosis is challenging, leading to empirical treatment.
- Empirical treatment results in overtreatment and underdiagnosis of other conditions.
- Accurate diagnosis is crucial for effective patient management.
Purpose of the Study:
- To determine if ultrasound (eFASH) improves correct management of suspected extrapulmonary tuberculosis.
- To reduce overtreatment of tuberculosis and underdiagnosis of alternative conditions.
- To assess the impact of an eFASH-guided algorithm on patient outcomes.
Main Methods:
- Randomized controlled trial in Tanzania with 650 HIV-positive and -negative adults.
- Intervention group used eFASH, chest X-ray, and microbiology for management.
- Control group followed national guidelines; treatment initiated based on microbiology or physician discretion.
Main Results:
- Primary outcome: proportion of correctly managed patients at 6 months.
- Secondary outcomes: symptom-free status at 2 and 6 months, and time to death.
- Study aims to provide data on the efficacy of eFASH in a real-world setting.
Conclusions:
- Ultrasound-assisted diagnosis may enhance management of extrapulmonary tuberculosis.
- Improved diagnostic accuracy can reduce unnecessary anti-tuberculosis drug use.
- This approach could significantly impact patient care in resource-limited settings.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

